Business
SenesTech Reports First Quarter 2025 Financial Results 40% Revenue Growth in Evolve™, Record Gross Profit Margins of 65%, and Continued Progress Toward Profitability
SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-registered rodent birth control products today announced its financial results for the first quarter ended March 31, 2024.
About this update from Senestech, Inc.
[{"type":"text","content":"SURPRISE, Ariz., May 8, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-registered rodent birth control products today announced its financial results for the first quarter ended March 31, 2024.","length":306,"tagName":"p"},{"type":"image","alt":"SenesTech, Inc. has developed and is in the process of commercializing a proprietary technology for managing animal pest populations, primarily rat populations, through fertility control. (PRNewsfoto/SenesTech, Inc.)","displaySize":"","headline":null,"caption":"SenesTech, Inc. has developed and is in the process of commercializing a proprietary technology for managing animal pest populations, primarily rat populations, through fertility control. (PRNewsfoto/SenesTech, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":56,"url":"https://media.zenfs.com/en/prnewswire.com/f9358a298cf18da745be407dc7987d6e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/XA_HpDcDuVrEv9YnblyoCQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTk5O2NmPXdlYnA-/https://media.zenfs.com/en/prnewswire.com/f9358a298cf18da745be407dc7987d6e","width":400,"height":56}},"href":"https://mma.prnewswire.com/media/1503420/SenesTech_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Q1 2025 Highlights","length":18,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenues increased 17% to $485,000 from $415,000 in Q1 2024.","length":60,"tagName":"p"}]},{"val":[{"type":"text","content":"Evolve product sales grew 40% year-over-year, now representing 79% of total revenue.","length":84,"tagName":"p"}]},{"val":[{"type":"text","content":"Gross profit margin expanded to 64.5%, a record for the Company, compared to 32.5% in Q1 2024.","length":94,"tagName":"p"}]},{"val":[{"type":"text","content":"Net loss for Q1 2025 was $1.7 million, compared to $1.8 million in Q1 2024.","length":75,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EBITDA loss improved to $1.5 million, compared to $1.7 million in the prior year quarter.","length":98,"tagName":"p"}]},{"val":[{"type":"text","content":"Annualized cost reductions of $2 million expected to begin impacting results in Q2 2025.","length":88,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"l...